EE9400346A - Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadid - Google Patents

Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadid

Info

Publication number
EE9400346A
EE9400346A EE9400346A EE9400346A EE9400346A EE 9400346 A EE9400346 A EE 9400346A EE 9400346 A EE9400346 A EE 9400346A EE 9400346 A EE9400346 A EE 9400346A EE 9400346 A EE9400346 A EE 9400346A
Authority
EE
Estonia
Prior art keywords
galanin
pro
preparation process
pharmaceutical preparations
preparations containing
Prior art date
Application number
EE9400346A
Other languages
English (en)
Inventor
Bartfai Tamas
H�kfelt Tomas
Langel Ulo
Ahren Bo
Lindskog Stefan
Consolo Silvana
Land Tiit
Wiesenfeld-Hallin Zsuzsanna
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9400346A publication Critical patent/EE9400346A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EE9400346A 1991-05-15 1994-11-03 Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadid EE9400346A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101472A SE9101472D0 (sv) 1991-05-15 1991-05-15 Galanin antagonist

Publications (1)

Publication Number Publication Date
EE9400346A true EE9400346A (et) 1996-04-15

Family

ID=20382742

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400346A EE9400346A (et) 1991-05-15 1994-11-03 Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadid

Country Status (24)

Country Link
EP (2) EP0585300B1 (et)
JP (1) JPH06507629A (et)
KR (1) KR100221769B1 (et)
AT (1) ATE149525T1 (et)
AU (1) AU664180B2 (et)
CA (1) CA2109503A1 (et)
CZ (1) CZ242293A3 (et)
DE (2) DE69217937T2 (et)
DK (1) DK0585300T3 (et)
EE (1) EE9400346A (et)
ES (1) ES2098510T3 (et)
FI (1) FI935010A (et)
GR (1) GR3023150T3 (et)
HU (1) HUT65810A (et)
IE (1) IE921555A1 (et)
IS (1) IS3866A (et)
NO (1) NO934098D0 (et)
PL (1) PL171497B1 (et)
SE (1) SE9101472D0 (et)
SG (1) SG43921A1 (et)
SI (1) SI9200081B (et)
SK (1) SK127793A3 (et)
WO (1) WO1992020709A1 (et)
YU (1) YU50592A (et)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107400A0 (en) * 1992-11-10 1994-01-25 Cortech Inc Bradykinin antagonists
FR2716205B1 (fr) * 1994-02-17 1996-04-12 Rhone Poulenc Rorer Sa Récepteur galanine, acides nucléiques, cellules transformées et utilisations.
US5972624A (en) * 1996-01-24 1999-10-26 Synaptic Pharmaceutical Corporation Method of identifying ligands which bind recombinant galanin receptor (GALR2)
DE819167T1 (de) 1996-01-24 1998-04-09 Synaptic Pharma Corp Dns codierend für galanin galr2 rezeptoren und deren verwendung
DK1342410T3 (da) 1996-07-24 2010-05-31 Neurotargets Ltd Anvendelse af en galaninagonist til fremstilling af et medikament til forbedring af hukommelse og andre kognitive funktioner
US6329197B2 (en) 1996-10-09 2001-12-11 Synaptic Pharmaceutical Corporation DNA encoding galanin GALR3 receptors and uses thereof
WO1999005302A1 (en) * 1997-07-24 1999-02-04 The Perkin-Elmer Corporation Conjugates of transporter peptides and nucleic acid analogs, and their use
DE69925116T2 (de) 1998-03-25 2005-11-17 Takeda Pharmaceutical Co. Ltd. Neue, physiologisch aktive peptide und ihre verwendung.
WO2000071533A2 (en) * 1999-05-21 2000-11-30 Ortho-Mcneil Pharmaceutical, Inc. 1,4-dithiin and 1,4-dithiepin- 1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor
US6407136B1 (en) 1999-05-21 2002-06-18 Ortho-Mcneil Pharmaceutical, Inc. 1,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor
EP1089439A1 (en) * 1999-09-28 2001-04-04 TELEFONAKTIEBOLAGET L M ERICSSON (publ) Interleaver and method for interleaving an input data bit sequence using a coded storing of symbol and additional information
US7220775B2 (en) 2002-08-07 2007-05-22 H. Lundbeck A/S Compound useful for the treatment of neuropathic pain
WO2006047302A1 (en) 2004-10-21 2006-05-04 Transtech Pharma, Inc. Bissulfonamide compounds as agonists of galr1, compositions, and methods of use
GB0523550D0 (en) 2005-11-18 2005-12-28 Hunter Fleming Ltd Therapeutic uses of steroidal compounds
EP2913056A1 (en) * 2006-01-05 2015-09-02 The University of Utah Research Foundation Methods and compositions related to improving properties of pharmacological agents targeting nervous system
WO2010028673A1 (en) * 2008-09-09 2010-03-18 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
WO2012082942A2 (en) 2010-12-15 2012-06-21 Neuroadjuvants, Inc. Neuropeptide analogs, compositions, and methods for treating pain
AU2014234400B2 (en) 2013-03-21 2017-11-16 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
ES2624961T3 (es) 2013-03-21 2017-07-18 Sanofi-Aventis Deutschland Gmbh Síntesis de productos de péptido que contienen imida cíclica
CN110055340B (zh) * 2019-04-11 2021-01-01 中国农业大学 一种食品中牛源成分快速检测方法及试剂盒

Also Published As

Publication number Publication date
AU1785892A (en) 1992-12-30
PL171497B1 (pl) 1997-05-30
GR3023150T3 (en) 1997-07-30
SI9200081A (en) 1992-12-31
SK127793A3 (en) 1994-04-06
ES2098510T3 (es) 1997-05-01
SG43921A1 (en) 1997-11-14
EP0585300A1 (en) 1994-03-09
NO934098L (no) 1993-11-12
CA2109503A1 (en) 1992-11-16
FI935010A0 (fi) 1993-11-12
DE585300T1 (de) 1994-06-16
DE69217937D1 (de) 1997-04-10
DE69217937T2 (de) 1997-06-19
AU664180B2 (en) 1995-11-09
NO934098D0 (no) 1993-11-12
YU50592A (sh) 1994-09-09
SE9101472D0 (sv) 1991-05-15
IE921555A1 (en) 1992-11-18
IS3866A (is) 1992-11-16
JPH06507629A (ja) 1994-09-01
DK0585300T3 (da) 1997-09-01
WO1992020709A1 (en) 1992-11-26
EP0585300B1 (en) 1997-03-05
EP0514361A1 (en) 1992-11-19
ATE149525T1 (de) 1997-03-15
CZ242293A3 (en) 1994-07-13
FI935010A (fi) 1993-11-12
KR100221769B1 (ko) 1999-10-01
SI9200081B (sl) 2000-08-31
HUT65810A (en) 1994-07-28

Similar Documents

Publication Publication Date Title
EE9400346A (et) Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadid
FI910286A0 (fi) Analoger av humant insulin och preparat innehaollande dessa.
TW349867B (en) Pharmaceutical composition for inducing a cytotoxic T-lymphocyte responses
DE69028671D1 (de) Löslisches extrazellulares Fragment des menschlischen IFN-beta 2/IL-6-Rezeptors, seine Herstellung und diesen Fragment enthaltende pharmazeutische Mischung
ZA946142B (en) Therapeutic heterocycles
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
DE69230670D1 (de) Zusammensetzungen, die eine blutgerinnselpolymermatrix zur verabreichung von osteogenen proteinen enthalten
EP1233013A4 (en) phenylalanine derivatives
NO871574D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive peptider.
ATE191719T1 (de) Analoge des calcitonin aus lachs, ihre herstellung und ihre verwendung als medizin und als analytische reagentien
ES2059545T5 (es) Hormonas de glicoproteinas modificadas por mutagenesis dirigida por puntos y metodos de uso de tales hormonas.
ES2157886T3 (es) Composiciones tensioactivas y procedimientos.
SE8800080L (sv) Laekemedelskomposition
NZ235497A (en) Peptides (possibly related to hirudin) and pharmaceutical compositions for reducing blood coagulation
ATE253590T1 (de) Peptide, bronchodilator und den blutstrom verbesserndes mittel
DE59006159D1 (de) Verwendung von macrolactonen als antiallergica.
DE3850044D1 (de) Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.
IT1217177B (it) Palmitoil-fruttosio-1,6-difosfato,suo uso terapeutico e relativi metodi di preparazione
RU93058426A (ru) Антогонист галанина, способ его получения, пептид, фармацевтический состав и способ лечения
DE59008693D1 (de) Gewebs-Plasminogen-Aktivator-Derivat.
IT1216535B (it) O_(1,2_di_0_acetilglicero_3_fosforil)etanolamina, procedimento per la sua preparazione e suo uso terapeutico.
TH14318EX (th) นิวคลีโอไซด์ที่ใช้ในการรักษาโรค
IT8819665A0 (it) (1,2_di_0_acetil_glicero_3_fosforil)_colina, procedimento per la sua preparazione e suo uso terapeutico.
NO880831D0 (no) Rekombinant human vevsplasminogen-aktivatorblanding.
GB8903389D0 (en) Accessories for use by motorists and others such as ramblers,walkers and climbers